The Levels of Lipids, Lipoproteins and Apolipoproteins in Healthy People in the Central Region of the Black Sea

Lipids, lipoproteins and apolipoproteins are among the risk factors for the most serious health problem of the age-coronary artery disease (CAD). They vary from country to country, from area to area within a country, depending on genetic, environmental, dietary and many other factors. Our aim was to...

Full description

Saved in:
Bibliographic Details
Published in:Japanese Heart Journal Vol. 40; no. 4; pp. 427 - 434
Main Authors: ADAM, Bahattin, TALU, Cengiz, BEDIR, Abdulkerim, ALVUR, Muhlise, SAGKAN, Olcay
Format: Journal Article
Language:English
Published: Tokyo International Heart Journal Association 1999
Japanese Heart Journal Association
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Lipids, lipoproteins and apolipoproteins are among the risk factors for the most serious health problem of the age-coronary artery disease (CAD). They vary from country to country, from area to area within a country, depending on genetic, environmental, dietary and many other factors. Our aim was to determine the levels of lipids, lipoproteins and apolipoproteins in healthy people in the central Black Sea region of Turkey. Subjects included 1348 volunteers (682 women, 666 men) referred to the Medical Faculty hospital from the study area. The population consisted of healthy people or those whose disease was not affecting the metabolism of lipids. Cholesterol, triglyceride and HDL-cholesterol levels in the obtained serum samples were measured spectrophotometrically, while apolipoprotein A-I, apolipoprotein B, apolipoprotein E and lipoprotein(a) levels were measured nephelometrically. The levels of lipid parameters were as follows: total cholesterol for men was 4.22±1.00mmol/l (mean arithmetic±SD), triglyceride 1.20 mmol/l (0.30-4.44) [geometric mean (range)], HDL-cholesterol 0.88±0.22 mmol/l, LDL-cholesterol 2.69±0.85 mmol/l, apolipoprotein A-I 1.26±0.22 mmol/l apolipoprotein B 1.12±0.32 mmol/l, apolipoprotein E 0.037±0.012 mmol/l and lipoprotein(a) 0.25 g/l (0.03-2.75); total cholesterol for women was 4.53±1.00 mmol/l, triglyceride 1.05 mmol/l (0.28-4.50), HDL-cholesterol 1.08±0.26 mmol/l, LDL-cholesterol 2.87±0.88 mmol/l, apolipoprotein A-I 1.45±0.25 mmol/l, apolipoprotein B 1.11±0.31 mmol/l, apolipoprotein E 0.039±0.011 mmol/l and lipoprotein(a) 0.22 g/l (0.03-2.16). In conclusion, our study in four different regions in Turkey reflected that the people living in the central Black Sea region are less vulnerable to the risk of CAD, although at a relatively higher risk compared to some other countries.
AbstractList Lipids, lipoproteins and apolipoproteins are among the risk factors for the most serious health problem of the age--coronary artery disease (CAD). They vary from country to country, from area to area within a country, depending on genetic, environmental, dietary and many other factors. Our aim was to determine the levels of lipids, lipoproteins and apolipoproteins in healthy people in the central Black Sea region of Turkey. Subjects included 1348 volunteers (682 women, 666 men) referred to the Medical Faculty hospital from the study area. The population consisted of healthy people or those whose disease was not affecting the metabolism of lipids. Cholesterol, triglyceride and HDL-cholesterol levels in the obtained serum samples were measured spectrophotometrically, while apolipoprotein A-I, apolipoprotein B, apolipoprotein E and lipoprotein(a) levels were measured nephelometrically. The levels of lipid parameters were as follows: total cholesterol for men was 4.22 +/- 1.00 mmol/l (mean arithmetic +/- SD), triglyceride 1.20 mmol/l (0.30-4.44) [geometric mean (range)], HDL-cholesterol 0.88 +/- 0.22 mmol/l, LDL-cholesterol 2.69 +/- 0.85 mmol/l, apolipoprotein A-I 1.26 +/- 0.22 mmol/l apolipoprotein B 1.12 +/- 0.32 mmol/l, apolipoprotein E 0.037 +/- 0.012 mmol/l and lipoprotein(a) 0.25 g/l (0.03-2.75); total cholesterol for women was 4.53 +/- 1.00 mmol/l, triglyceride 1.05 mmol/l (0.28-4.50), HDL-cholesterol 1.08 +/- 0.26 mmol/l, LDL-cholesterol 2.87 +/- 0.88 mmol/l, apolipoprotein A-I 1.45 +/- 0.25 mmol/l, apolipoprotein B 1.11 +/- 0.31 mmol/l, apolipoprotein E 0.039 +/- 0.011 mmol/l and lipoprotein(a) 0.22 g/l (0.03 2.16). In conclusion, our study in four different regions in Turkey reflected that the people living in the central Black Sea region are less vulnerable to the risk of CAD, although at a relatively higher risk compared to some other countries.
Lipids, lipoproteins and apolipoproteins are among the risk factors for the most serious health problem of the age-coronary artery disease (CAD). They vary from country to country, from area to area within a country, depending on genetic, environmental, dietary and many other factors. Our aim was to determine the levels of lipids, lipoproteins and apolipoproteins in healthy people in the central Black Sea region of Turkey. Subjects included 1348 volunteers (682 women, 666 men) referred to the Medical Faculty hospital from the study area. The population consisted of healthy people or those whose disease was not affecting the metabolism of lipids. Cholesterol, triglyceride and HDL-cholesterol levels in the obtained serum samples were measured spectrophotometrically, while apolipoprotein A-I, apolipoprotein B, apolipoprotein E and lipoprotein(a) levels were measured nephelometrically. The levels of lipid parameters were as follows: total cholesterol for men was 4.22±1.00mmol/l (mean arithmetic±SD), triglyceride 1.20 mmol/l (0.30-4.44) [geometric mean (range)], HDL-cholesterol 0.88±0.22 mmol/l, LDL-cholesterol 2.69±0.85 mmol/l, apolipoprotein A-I 1.26±0.22 mmol/l apolipoprotein B 1.12±0.32 mmol/l, apolipoprotein E 0.037±0.012 mmol/l and lipoprotein(a) 0.25 g/l (0.03-2.75); total cholesterol for women was 4.53±1.00 mmol/l, triglyceride 1.05 mmol/l (0.28-4.50), HDL-cholesterol 1.08±0.26 mmol/l, LDL-cholesterol 2.87±0.88 mmol/l, apolipoprotein A-I 1.45±0.25 mmol/l, apolipoprotein B 1.11±0.31 mmol/l, apolipoprotein E 0.039±0.011 mmol/l and lipoprotein(a) 0.22 g/l (0.03-2.16). In conclusion, our study in four different regions in Turkey reflected that the people living in the central Black Sea region are less vulnerable to the risk of CAD, although at a relatively higher risk compared to some other countries.
Author TALU, Cengiz
ALVUR, Muhlise
SAGKAN, Olcay
ADAM, Bahattin
BEDIR, Abdulkerim
Author_xml – sequence: 1
  fullname: ADAM, Bahattin
  organization: Departments of Biochemistry and Clinical Biochemistry, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
– sequence: 2
  fullname: TALU, Cengiz
  organization: Departments of Biochemistry and Clinical Biochemistry, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
– sequence: 3
  fullname: BEDIR, Abdulkerim
  organization: Departments of Biochemistry and Clinical Biochemistry, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
– sequence: 4
  fullname: ALVUR, Muhlise
  organization: Departments of Biochemistry and Clinical Biochemistry, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
– sequence: 5
  fullname: SAGKAN, Olcay
  organization: Department of Cardiology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1217949$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10611907$$D View this record in MEDLINE/PubMed
BookMark eNpNkEFv1DAQhS1URLeFCz8A-YA4VGSxY8dOTlVZFYq0EgiKxM2aOONuFq8d7CxS_z2JdrX0MiO99-nN6F2QsxADEvKasyWvhPqw3WyXki1lqZ-RBReyLpQWv87IgrGSF7JW9Tm5yHnLGFdlLV6Qc84U5w3TCxLvN0jX-Bd9ptHRdT_0XX4_7zikOGIfMoXQ0Zsh-qdaH-gdgh83j_QbxsHjrIxT1grDmMDT7_jQxzBnzupHD_Y3_YHwkjx34DO-Ou5L8vPT7f3qrlh__fxldbMubKX5WDS8ZZXgugKAVrkOVNWgQyEYb2onqtphV9qWK-aYlhVjurW8xRqsbEqNWlySd4fc6eM_e8yj2fXZovcQMO6zUY3QkolqAq8OoE0x54TODKnfQXo0nJm5XjPVayQzU70T_OaYum932D1BD31OwNsjANmCdwmC7fN_ruS6kc2EXR-wbR7hAU8-pLG3Hk8nj6PUJ8duIBkM4h_J5Zsj
CODEN JHEJAR
CitedBy_id crossref_primary_10_1186_s12944_017_0581_8
crossref_primary_10_1016_S0022_2275_20_31581_9
crossref_primary_10_17826_cumj_512944
crossref_primary_10_1097_MCA_0b013e3282f399cf
crossref_primary_10_1536_jhj_42_281
Cites_doi 10.1161/01.CIR.87.4.1135
10.1001/jama.256.20.2823
10.1093/clinchem/38.4.566
10.1093/clinchem/41.1.139
10.1093/clinchem/41.11.1633
10.1016/0002-9149(92)90550-I
10.1016/0021-9150(93)90175-T
10.1016/0021-9150(95)05675-0
10.1136/jech.48.4.355
10.1001/jama.269.23.3002
10.1016/S0022-2275(20)40067-7
10.1093/clinchem/42.4.515
10.1001/archinte.141.9.1128
10.1136/jech.46.5.470
10.1016/0009-8981(91)90106-M
10.1016/0009-8981(78)90066-9
10.2337/diab.35.12.1374
10.1016/0735-1097(92)90520-W
10.1161/01.CIR.79.1.8
10.1001/jama.257.16.2176
10.1136/bmj.301.6763.1248
10.1016/0021-9150(91)90007-P
10.1093/clinchem/18.6.499
10.1097/00007611-199708000-00008
10.1161/01.CIR.86.3.858
10.1016/0002-9149(86)90831-3
10.1161/01.CIR.74.4.758
10.1016/0002-9149(80)90516-0
10.1016/0021-9150(81)90103-9
10.1056/NEJM198308183090701
ContentType Journal Article
Copyright 1999 by the Japanese Heart Journal
2000 INIST-CNRS
Copyright_xml – notice: 1999 by the Japanese Heart Journal
– notice: 2000 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1536/jhj.40.427
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1348-673X
EndPage 434
ExternalDocumentID 10_1536_jhj_40_427
10611907
1217949
article_jhj_40_4_40_4_427_article_char_en
Genre Journal Article
GeographicLocations Asia
Turkey
GeographicLocations_xml – name: Turkey
GroupedDBID .55
.GJ
29J
2WC
3O-
53G
5GY
5RE
AABQG
AAUGY
ABOCM
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
E3Z
F5P
GX1
JSF
JSH
KQ8
OK1
RJT
RNS
RZJ
SDH
TKC
TR2
W2D
WH7
X7J
X7M
XSB
ZGI
ZXP
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c571t-91b053175aaab6fda659efe330198f358fed2cb160f0745007bc1be8ac4927e73
ISSN 0021-4868
IngestDate Sat Aug 17 02:20:26 EDT 2024
Fri Aug 23 00:45:53 EDT 2024
Sat Sep 28 08:35:54 EDT 2024
Sun Oct 29 17:08:38 EDT 2023
Thu Aug 17 20:24:46 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 4
Keywords Human
Risk factor
Cardiovascular disease
Lipids
Apolipoprotein
Lipoprotein
Coronary heart disease
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c571t-91b053175aaab6fda659efe330198f358fed2cb160f0745007bc1be8ac4927e73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/jhj/40/4/40_4_427/_article/-char/en
PMID 10611907
PQID 69374035
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_69374035
crossref_primary_10_1536_jhj_40_427
pubmed_primary_10611907
pascalfrancis_primary_1217949
jstage_primary_article_jhj_40_4_40_4_427_article_char_en
PublicationCentury 1900
PublicationDate 19990000
PublicationDateYYYYMMDD 1999-01-01
PublicationDate_xml – year: 1999
  text: 19990000
PublicationDecade 1990
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Japanese Heart Journal
PublicationTitleAlternate Jpn Heart J
PublicationYear 1999
Publisher International Heart Journal Association
Japanese Heart Journal Association
Publisher_xml – name: International Heart Journal Association
– name: Japanese Heart Journal Association
References 18) Jauhiainen M, Koskinen P, Ehnholm C, et al. Lipoprotein[a] and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991; 89: 59.
7) Wilson PWF, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterol. Am J Cardiol 1980; 46: 649.
19) Maciejko JJ, Holmes RD, Kottke AB, et al. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med. 1983; 309: 385.
2) Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screens of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823.
16) Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle-aged men. BJM 1990; 301: 1248.
31) Contois JH, McNamara JR, Lammi-Keefe CJ, et al. Reference intervals for plasma apolipoprotein B determined with a standardised commercial immunoturbidimetric assay: result from the Framingham Offspring Study. Clin Chem 1996; 42: 515.
4) Connelly PW, Maclean DR, Horlick L, O'Connor B, Petrasovits A, Little A, Canadian Heart Health Surveys Research Group. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. CMAJ 1992; 146: 1977.
15) Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein (a), plasma lipids and other lipoprotein with coronary artery disease documented by angiography. Circulation 1986; 74: 758.
6) Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease and death: the Framingham study. Arch Intern Med 1981; 141: 1128.
13) Tervahauta M, Pekkanen J, Kivinen P, et al. Prevalence of coronary heart disease and associated risk factors among elderly Finnish men in the Seven Countries Study. Atherosclerosis 1993; 104: 47.
14) Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo Bon G, Qunici GB. Lipoprotein (a) and the risk for myocardial infarction. Atherosclerosis 1981; 38: 51.
21) Eto M, Watanabe K, Iwashima Y, et al. Apolipoprotein E polymorphism, and hyperlipidemia in type II diabetics. Diabetes 1986; 35: 1374.
23) Onat A, Surdum-Avci G, Senocak M, Örnek E, Gözükara Y. Plasma lipids and their interrelationship in Turkish adults. J Epidemiology Community Health 1992; 46: 470.
27) Jenner JL, Ordovas JM, Lamon-Fava S, et al. Effects of age, sex and menopausal status on plasma lipoprotein(a) levels: The Framingham Offspring Study. Circulation 1993; 87: 1135.
11) Watkins LO, Neaton JD, Kuller LH. Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the Multiple Risk Factor Intervention Trial. Am J Cardiol 1986; 57: 538.
24) Friedwald WT, Levy RI and Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499.
5) Ettinger WH, Wahl PW, Kuller LH, et al. Lipoprotein lipids in older people: result from the Cardiovascular Health Study. Circulation 1992; 86: 858.
20) Vergani C, Trovato G, Dioguardi N. Serum total lipid, lipoprotein cholesterol, apoprotein A and B in cardiovascular disease. Clin Chim Acta 1978; 87: 127.
32) Zunic G, Jelic-lvanovic Z, Spasic S, Stojiljkovic A, Majkic-Singh N. Reference values for apolipoproteins A-I and B in healthy subjects by age. Clin Chem 1992; 38: 566.
10) Barter PJ, Rye K-A. High-density lipoproteins and coronary heart disease. Atherosclerosis 1996; 121: 1.
26) Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA 1993; 269: 3002.
3) Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987; 257: 2176.
28) Fong PC, Tam SC, Tai Y, Lau C, Lee J, Sha Y. Serum lipid and apolipoprotein distributions in Hong Kong Chinese. J Epidemiol Community Health 1994; 48: 356.
30) Noma A, Hata Y, Goto Y. Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III ve E in healthy Japanese by turbidimetric immunoassay: reference values and age- and sex-related differences. Clinica Chimica Acta 1991; 199: 147.
1) National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994; 89: 1329.
8) Grundy SM. Role of low-density lipoproteins in atherogenesis and development of coronary heart disease. Clin Chem 1995; 41: 139.
25) Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease. (the PROCAM experience) Am J Cardiol 1992; 70: 733.
29) Leino A, Impivaara O, Kaitsaari M, Jarvisalo J. Serum concentrations of apolipoprotein A-I, apolipoprotein B and lipoprotein(a) in a population sample. Clin Chem 1995; 41: 1633.
12) Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989; 79: 8.
17) Genest J Jr, McNamara JR, Ordovas JM, et al. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 1992; 19: 792.
9) Willelms JP, Saunders JT, Hunt DE, Schorling JB. Prevalence of coronary heart disease risk factors among rural blacks: a community-based study. South Med J 1997; 90: 814.
22) Mahley RW, Palaoglu EK, Atak Z, et al. Turkish heart study: lipids, lipoproteins and apolipoproteins. J Lipid Res 1995; 36: 839.
23
24
25
26
27
28
29
30
31
10
32
11
12
13
14
15
16
(22) 1995; 36
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – ident: 4
– ident: 27
  doi: 10.1161/01.CIR.87.4.1135
– ident: 2
  doi: 10.1001/jama.256.20.2823
– ident: 32
  doi: 10.1093/clinchem/38.4.566
– ident: 8
  doi: 10.1093/clinchem/41.1.139
– ident: 29
  doi: 10.1093/clinchem/41.11.1633
– ident: 25
  doi: 10.1016/0002-9149(92)90550-I
– ident: 13
  doi: 10.1016/0021-9150(93)90175-T
– ident: 10
  doi: 10.1016/0021-9150(95)05675-0
– ident: 28
  doi: 10.1136/jech.48.4.355
– ident: 26
  doi: 10.1001/jama.269.23.3002
– volume: 36
  start-page: 839
  issn: 0022-2275
  issue: 4
  year: 1995
  ident: 22
  doi: 10.1016/S0022-2275(20)40067-7
– ident: 31
  doi: 10.1093/clinchem/42.4.515
– ident: 6
  doi: 10.1001/archinte.141.9.1128
– ident: 23
  doi: 10.1136/jech.46.5.470
– ident: 30
  doi: 10.1016/0009-8981(91)90106-M
– ident: 20
  doi: 10.1016/0009-8981(78)90066-9
– ident: 21
  doi: 10.2337/diab.35.12.1374
– ident: 17
  doi: 10.1016/0735-1097(92)90520-W
– ident: 12
  doi: 10.1161/01.CIR.79.1.8
– ident: 1
– ident: 3
  doi: 10.1001/jama.257.16.2176
– ident: 16
  doi: 10.1136/bmj.301.6763.1248
– ident: 18
  doi: 10.1016/0021-9150(91)90007-P
– ident: 24
  doi: 10.1093/clinchem/18.6.499
– ident: 9
  doi: 10.1097/00007611-199708000-00008
– ident: 5
  doi: 10.1161/01.CIR.86.3.858
– ident: 11
  doi: 10.1016/0002-9149(86)90831-3
– ident: 15
  doi: 10.1161/01.CIR.74.4.758
– ident: 7
  doi: 10.1016/0002-9149(80)90516-0
– ident: 14
  doi: 10.1016/0021-9150(81)90103-9
– ident: 19
  doi: 10.1056/NEJM198308183090701
SSID ssj0016283
Score 1.3061469
Snippet Lipids, lipoproteins and apolipoproteins are among the risk factors for the most serious health problem of the age-coronary artery disease (CAD). They vary...
Lipids, lipoproteins and apolipoproteins are among the risk factors for the most serious health problem of the age--coronary artery disease (CAD). They vary...
SourceID proquest
crossref
pubmed
pascalfrancis
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 427
SubjectTerms Adolescent
Adult
Aged
Apolipoprotein
Apolipoproteins - blood
Apolipoproteins A - blood
Apolipoproteins B - blood
Apolipoproteins E - blood
Biological and medical sciences
Blood Pressure - physiology
Cardiology. Vascular system
Coronary heart disease
Female
Heart
Humans
Lipid
Lipids - blood
Lipoprotein
Lipoproteins - blood
Male
Medical sciences
Middle Aged
Turkey
Title The Levels of Lipids, Lipoproteins and Apolipoproteins in Healthy People in the Central Region of the Black Sea
URI https://www.jstage.jst.go.jp/article/jhj/40/4/40_4_427/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/10611907
https://search.proquest.com/docview/69374035
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Japanese Heart Journal, 1999, Vol.40(4), pp.427-434
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZoQQgJId4EKFiCW0nJy3FyLHSrIko5kEq9Rc7aFrtaJavdDRL_nhnbeYEQcOBiRd7Ea3k-z4zH8yDkdagqTErO_JDHzAfuB3su5rGfaR0LEMiBMt4WZ1_4xVV2MktmQ8T10PdfKQ19QGuMnP0HaveDQgc8A82hBapD-9d0X6EnkPHRWC3WC2lIBU-NScqAPjEmQyvWZxj1LWoXFPnduZV3LpDOf_MQazhY7dI4FaDlD1iNmKi3IHqxpCWOtNkdjidsfAIs-vpbnkKs2oml9h2I0s3Ewnq8-tZuBqutdAF7-ZjbRnA-zWzZnI7b2uRMDlXJiHUmNkeAk8KJNXH-wuCZqUCz_Lo8SoKj_pNxFu2Lz-Xp5fl5Wcyuij1yPQIGhDUVTj587G-X0simZ-3m59LWwthvh5EnisqNJejqmITh9lpsYfNoW_Xk98cSo54Ud8kdd66gxxYQ98g1Vd8nNz85z4kHpAFcUIsL2mhqcfGGjhFAARX0J1TQRU0dKqhFBfYA_alDBbWowDGx16CCAioeksvTWfH-zHfFNvw54-EOhF6F_JgzIUSVailSliutYhAAeaZjlmklo3kVpoEGrZOBalnNw0plYp7kEVc8fkT266ZWTwgNZSoxtoWpCgsc8FwoOMelUaCkCqRKPPKqW9lybXOqlHgWhfUvYf3LJChh_T2S2UXv33F7qn_HNRHvf8FIRWACHjmYkGn4lwjlT-6Rlx3ZSuCmeEUGm6Npt2UK2noSxMwjjy01RxNMQ1Ce-dM_fvuM3LK5PdBO95zs7zatOiB7W9m-MDD8AUi9nbs
link.rule.ids 315,782,786,4030,27934,27935,27936
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+levels+of+lipids%2C+lipoproteins+and+apolipoproteins+in+healthy+people+in+the+central+region+of+the+Black+Sea&rft.jtitle=Japanese+heart+journal&rft.au=Adam%2C+B&rft.au=Talu%2C+C&rft.au=Bedir%2C+A&rft.au=Alvur%2C+M&rft.date=1999&rft.issn=0021-4868&rft.volume=40&rft.issue=4&rft.spage=427&rft.epage=434&rft_id=info:doi/10.1536%2Fjhj.40.427&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-4868&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-4868&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-4868&client=summon